4//SEC Filing
Sullivan Christopher Ryan 4
Accession 0001879785-21-000039
CIK 0001534120other
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 5:17 PM ET
Size
4.6 KB
Accession
0001879785-21-000039
Insider Transaction Report
Form 4
Sullivan Christopher Ryan
Chief Financial Officer
Transactions
- Purchase
Common Stock
2021-12-10$1.57/sh+955$1,499→ 9,004 total
Footnotes (1)
- [F1]These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan.
Documents
Issuer
Avalo Therapeutics, Inc.
CIK 0001534120
Entity typeother
Related Parties
1- filerCIK 0001810417
Filing Metadata
- Form type
- 4
- Filed
- Dec 13, 7:00 PM ET
- Accepted
- Dec 14, 5:17 PM ET
- Size
- 4.6 KB